Literature DB >> 9619838

Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts.

A Kilbey1, C Bartholomew.   

Abstract

The Evi-1 gene encodes a zinc finger transcriptional repressor protein that normally plays a role in development and is frequently activated in myeloid leukaemias. Evi-1 has two distinct DNA binding domains, ZF1 and ZF2, and a defined repressor domain but the function of the remainder of the molecule is unknown. The ZF2 and repressor domains have been shown to be required for transformation and we show here that ZF1 is also required. An alternative splice variant of Evi-1, designated delta324, encodes a protein which lacks a portion of the ZF1 DNA binding domain and the intervening amino acids 239-514 (designated IR) located between ZF1 and the repressor domain. We show that delta324 can neither bind ZF1, repress transcription through this site nor transform Rat1 fibroblasts. Reconstitution studies demonstrate that the defect in delta324 is partially complemented by recreating the ZF1 DNA binding activity. However, full function also requires the IR region which has transcriptional repressor activity. This study shows therefore, that ZF1, ZF2 and repressor domains and the IR region all contribute to the transformation efficiency of the Evi-1 protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619838     DOI: 10.1038/sj.onc.1201732

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.

Authors:  Kathryn E Boyd; Ying-Yi Xiao; Kai Fan; Amanda Poholek; Neal G Copeland; Nancy A Jenkins; Archibald S Perkins
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

2.  Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide.

Authors:  Yi Zhang; Géraldine Sicot; Xiaohui Cui; Marion Vogel; Charles A Wuertzer; Kimberly Lezon-Geyda; John Wheeler; Daniel A Harki; Katy A Muzikar; Daniel A Stolper; Peter B Dervan; Archibald S Perkins
Journal:  Biochemistry       Date:  2011-11-10       Impact factor: 3.162

3.  EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.

Authors:  Emilie A Bard-Chapeau; Jayantha Gunaratne; Pankaj Kumar; Belinda Q Chua; Julius Muller; Frederic A Bard; Walter Blackstock; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

4.  Correlations of common polymorphism of EVI-1 gene targeted by miRNA-206/133b with the pathogenesis of breast cancer.

Authors:  Tian-Yi Wang; Yin-Peng Huang; Ping Ma
Journal:  Tumour Biol       Date:  2014-06-17

5.  Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response.

Authors:  Sonja C Bingemann; Torsten A Konrad; Rotraud Wieser
Journal:  FEBS J       Date:  2009-10-16       Impact factor: 5.542

6.  Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.

Authors:  A Sayadi; J Jeyakani; S H Seet; C-L Wei; G Bourque; F A Bard; N A Jenkins; N G Copeland; E A Bard-Chapeau
Journal:  Oncogene       Date:  2015-08-03       Impact factor: 9.867

7.  EVI1 splice variants modulate functional responses in ovarian cancer cells.

Authors:  Punashi Dutta; Tuyen Bui; Kyle A Bauckman; Khandan Keyomarsi; Gordon B Mills; Meera Nanjundan
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

8.  Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells.

Authors:  D M Smith; S Patel; F Raffoul; E Haller; G B Mills; M Nanjundan
Journal:  Cell Death Differ       Date:  2010-05-28       Impact factor: 15.828

9.  Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability.

Authors:  Daniel J White; Richard D Unwin; Eric Bindels; Andrew Pierce; Hsiang-Ying Teng; Joanne Muter; Brigit Greystoke; Tim D Somerville; John Griffiths; Simon Lovell; Tim C P Somervaille; Ruud Delwel; Anthony D Whetton; Stefan Meyer
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.

Authors:  Chi Huu Nguyen; Katharina Bauer; Hubert Hackl; Angela Schlerka; Elisabeth Koller; Anastasiya Hladik; Dagmar Stoiber; Johannes Zuber; Philipp B Staber; Andrea Hoelbl-Kovacic; Louise E Purton; Florian Grebien; Rotraud Wieser
Journal:  Cell Death Dis       Date:  2019-12-10       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.